Palatin Technologies, Inc. (AMEX: PTN) is a biopharmaceutical company developing targeted receptor-specific peptide therapeutics to treat diseases with significant unmet medical need and commercial potential. The Company’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For further information, visit the Company’s Web site at www.palatin.com.
Noble Financial, a research driven, full-service investment banking boutique, is as discriminating with its invitations to institutional investors as it is with the companies invited to present. Rather than just focusing on crowding the conference floor, Noble Financial carefully invites a smaller audience of investors with a large appetite for the companies presenting; quality always trumps quantity. For more information or to view webcasts of today’s presentations, visit www.noblefcm.com.
Let us hear your thoughts below: